Perrigo Company plc $PRGO Position Increased by West Tower Group LLC

West Tower Group LLC boosted its position in shares of Perrigo Company plc (NYSE:PRGO) by 40.2% during the fourth quarter, Holdings Channel reports. The firm owned 242,955 shares of the company’s stock after buying an additional 69,714 shares during the quarter. Perrigo comprises approximately 7.6% of West Tower Group LLC’s holdings, making the stock its 2nd biggest position. West Tower Group LLC’s holdings in Perrigo were worth $3,382,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in Perrigo by 7.9% during the fourth quarter. Vanguard Group Inc. now owns 14,983,369 shares of the company’s stock worth $208,568,000 after purchasing an additional 1,101,154 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in Perrigo by 2.4% during the third quarter. Dimensional Fund Advisors LP now owns 7,695,238 shares of the company’s stock worth $171,367,000 after purchasing an additional 181,828 shares in the last quarter. State Street Corp lifted its position in shares of Perrigo by 9.5% in the second quarter. State Street Corp now owns 7,340,323 shares of the company’s stock valued at $196,134,000 after acquiring an additional 637,678 shares in the last quarter. Ion Asset Management Ltd. lifted its position in shares of Perrigo by 34.7% in the second quarter. Ion Asset Management Ltd. now owns 3,817,621 shares of the company’s stock valued at $102,007,000 after acquiring an additional 983,727 shares in the last quarter. Finally, Cooke & Bieler LP lifted its position in shares of Perrigo by 11.6% in the third quarter. Cooke & Bieler LP now owns 3,680,411 shares of the company’s stock valued at $81,963,000 after acquiring an additional 381,290 shares in the last quarter. 95.91% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on PRGO. Argus upgraded Perrigo to a “hold” rating in a research report on Wednesday, January 14th. Zacks Research upgraded Perrigo from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Weiss Ratings downgraded Perrigo from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, April 29th. Jefferies Financial Group restated a “hold” rating on shares of Perrigo in a research report on Thursday, February 26th. Finally, Canaccord Genuity Group reduced their price objective on Perrigo from $20.00 to $17.00 and set a “buy” rating on the stock in a research report on Friday, February 27th. One equities research analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $19.33.

Perrigo Stock Performance

Perrigo stock opened at $11.12 on Wednesday. The firm has a market capitalization of $1.54 billion, a P/E ratio of -0.85, a PEG ratio of 1.29 and a beta of 0.52. The stock has a fifty day moving average price of $10.83 and a 200 day moving average price of $13.37. Perrigo Company plc has a 52 week low of $9.23 and a 52 week high of $28.43. The company has a current ratio of 2.72, a quick ratio of 1.59 and a debt-to-equity ratio of 1.45.

Perrigo (NYSE:PRGO) last released its earnings results on Wednesday, May 6th. The company reported $0.43 EPS for the quarter, beating the consensus estimate of $0.39 by $0.04. The firm had revenue of $841.80 million during the quarter, compared to analyst estimates of $1.04 billion. Perrigo had a positive return on equity of 9.96% and a negative net margin of 43.50%.The business’s quarterly revenue was down 7.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.60 earnings per share. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. Equities research analysts anticipate that Perrigo Company plc will post 2.14 earnings per share for the current year.

Perrigo Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 16th. Investors of record on Friday, May 29th will be paid a $0.29 dividend. This represents a $1.16 annualized dividend and a yield of 10.4%. The ex-dividend date is Friday, May 29th. Perrigo’s dividend payout ratio is presently -8.85%.

Perrigo Company Profile

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.